Sign in

Evolvere BioSciences

Y Combinator Summer 2024 · Microbiology & synthetic biology · Europe

What it sells

Making Next-Generation Antibiotics that Outpace Bacterial Evolution

Funding history and coverage

Round dateStageAmountInvestorsSource
—Y Combinator Summer 2024—Y Combinatorycombinator.com

Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-11.

More startups in Microbiology & synthetic biology

  1. Microbiotica

    Develops precision microbiome medicines: defined live biotherapeutic products with known mechanisms of action, focused on immuno-oncology and inflammatory bowel disease.

    €42M · 2026-10-16Microbiology & synthetic biologyEurope

  2. BioConsortia

    BioConsortia develops microbial biological inputs for crops in nitrogen fixation, biocontrol and biostimulants, designed primarily for seed application, using its microbe…

    $15M · 2026-10-15Microbiology & synthetic biologyOther regions

  3. K-Bio Gateway

    Develops 'diet probiotics' and green-bio materials (DH24).

    Seed · KRW 1.2B · 2026-09-21Microbiology & synthetic biologyKorea

  4. Generare

    Molecular data for drug development from microbial genomes.

    €20M · 2026-04-02Microbiology & synthetic biologyEurope

  5. baCta

    Microorganisms as programmable factories for industrial ingredients.

    €7M · 2026-03-03Microbiology & synthetic biologyEurope

  6. ZBiotics

    ZBiotics makes genetically engineered probiotics.

    Y Combinator Winter 2018Microbiology & synthetic biologyNorth America

All startups in this market →